Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Non-Current Assets (2016 - 2025)

AC Immune (ACIU) has disclosed Non-Current Assets for 10 consecutive years, with $72.0 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets rose 7.02% to $72.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $72.0 million through Dec 2025, up 7.02% year-over-year, with the annual reading at $72.0 million for FY2025, 7.02% up from the prior year.
  • Non-Current Assets for Q4 2025 was $72.0 million at AC Immune, up from $67.3 million in the prior quarter.
  • The five-year high for Non-Current Assets was $72.0 million in Q4 2025, with the low at $60.0 million in Q4 2022.
  • Average Non-Current Assets over 5 years is $65.6 million, with a median of $65.0 million recorded in 2023.
  • The sharpest move saw Non-Current Assets surged 726.87% in 2021, then dropped 5.86% in 2022.
  • Over 5 years, Non-Current Assets stood at $63.8 million in 2021, then fell by 5.86% to $60.0 million in 2022, then increased by 8.26% to $65.0 million in 2023, then increased by 3.47% to $67.3 million in 2024, then rose by 7.02% to $72.0 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $72.0 million, $67.3 million, and $65.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.